pfizer glp-1 pipeline Scientists at The Wistar Institute have developed an innovative single-dose DNA delivery method that could revolutionize how we treat type 2 diabetes and obesity. Currently, popular incretin-mimicking drugs like Ozempic and Wegovy Pfizer boosts its obesity plans

Here's what happens after stopping GLP-1 weight-loss meds: Continued #weight loss for 1-2 months Then regain over next 4 months The more weight lost, the greater the regain From new analysis: pubmed.ncbi.nlm.nih.gov/40691794 Here's what happens after stopping GLP-1 weight-loss meds: Continued #weight loss for 1-2 months Then regain over next 4 months The more weight lost, the greater the regain From new analysis: pubmed.ncbi.nlm.nih.gov/40691794 Join the conversation

The results were not subjective assessments but machine-measured dermal changes

Saturated fat and cholesterol stay high

K., Shin, D

Reiter RJ, Sharma R, DA Chuffa LG, Zuccari DA, Amaral FG, Cipolla-Neto J (2024) Melatonin-mediated actions and circadian functions that improve implantation, fetal health and pregnancy outcome